Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...
Jim Smigiel, chief investment officer at financial-services firm SEI, weighed in on the U.S. outlook by saying "we see too many potential outcomes leading to a reacceleration in inflation and higher ...
Most of the meaningful progress in inflation appears to be "behind us at this stage" and price gains "may remain sticky at levels higher than the Federal Reserve would ideally like," said Rick Rieder, ...
Gas in underground storage is seen down by 259 billion cubic feet at 3,114 Bcf, according to the average estimate of nine analysts, brokers and traders surveyed by The Wall Street Journal. Estimates ...